Healthcare Triangle (NASDAQ:HCTI) Downgraded by Wall Street Zen to Sell

Healthcare Triangle (NASDAQ:HCTI) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Healthcare Triangle Price Performance

NASDAQ HCTI opened at $2.62 on Friday. The firm has a market cap of $15.27 million, a P/E ratio of -0.02 and a beta of 0.80. The stock’s 50-day moving average is $4.36 and its 200-day moving average is $27.13. Healthcare Triangle has a one year low of $1.37 and a one year high of $473.10.

Healthcare Triangle (NASDAQ:HCTI) last released its quarterly earnings results on Thursday, August 14th. The company reported ($0.58) EPS for the quarter. The firm had revenue of $3.56 million during the quarter.

Institutional Trading of Healthcare Triangle

An institutional investor recently bought a new position in Healthcare Triangle stock. Jane Street Group LLC bought a new position in shares of Healthcare Triangle, Inc. (NASDAQ:HCTI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,201,516 shares of the company’s stock, valued at approximately $33,000. Jane Street Group LLC owned approximately 20.60% of Healthcare Triangle at the end of the most recent quarter. 0.33% of the stock is currently owned by hedge funds and other institutional investors.

Healthcare Triangle Company Profile

Healthcare Triangle, Inc, a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.